agilon health, inc. Equity Method Investments
agilon health, inc. (AGL) had Equity Method Investments of $65.08 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2026-08-05
- 2026-06-30: Equity Method Investments $65.08M.
- 2026-03-31: Equity Method Investments $72.15M.
- 2025-12-31: Equity Method Investments $59.79M.
- 2025-09-30: Equity Method Investments $90.47M.
| Period end | Equity Method Investments |
|---|---|
| 2026-06-30 | $65.08M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $72.15M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $59.79M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $90.47M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $77.91M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $73.03M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $61.76M 10-K · filed 2026-02-25 |
| 2024-09-30 | $53.95M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $51.01M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $53.67M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $44.75M 10-K · filed 2025-02-25 |
| 2023-09-30 | $39.17M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $26.71M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $17.35M 10-K · filed 2024-02-27 |
| 2021-09-30 | $13.05M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $12.00M 10-Q · filed 2021-08-04 |
| 2020-12-31 | $8.50M 10-Q · filed 2021-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |